Share on StockTwits

Research analysts at Morgan Stanley initiated coverage on shares of Spire Healthcare Group PLC (LON:SPI) in a report released on Thursday. The firm set an “overweight” rating and a GBX 272 ($4.50) price target on the stock. Morgan Stanley’s price objective indicates a potential upside of 19.30% from the company’s current price.

Spire Healthcare Group PLC (LON:SPI) opened at 245.75 on Thursday. Spire Healthcare Group PLC has a 1-year low of GBX 208.00 and a 1-year high of GBX 230.00. The stock’s 50-day moving average is GBX 215.8 and its 200-day moving average is GBX 215.8.

A number of other firms have also recently commented on SPI. Analysts at JPMorgan Chase & Co. initiated coverage on shares of Spire Healthcare Group PLC in a research note on Thursday. They set an “overweight” rating and a GBX 336 ($5.56) price target on the stock. Separately, analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Spire Healthcare Group PLC in a research note on Thursday. They now have a GBX 320 ($5.30) price target on the stock. Finally, analysts at Investec reiterated a “buy” rating on shares of Spire Healthcare Group PLC in a research note on Thursday. They now have a GBX 285 ($4.72) price target on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.